Dexcom Inc
XBER:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dexcom Inc
XBER:DC4
|
US |
|
Vaxart Inc
OTC:VXRT
|
US |
|
Tower Resources PLC
F:ULF1
|
UK |
|
A
|
Aeluma Inc
OTC:ALMU
|
US |
|
Roche Holding AG
F:RHO
|
CH |
|
A
|
AdvanSix Inc
SWB:960
|
US |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 67.13 EUR with a low forecast of 57.78 EUR and a high forecast of 89.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
67.13
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 67.13 EUR with a low forecast of 57.78 EUR and a high forecast of 89.71 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.
What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Operating Income over the next 5 years is 19%.
What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
